Clinical Trials Logo

Insomnia, Primary clinical trials

View clinical trials related to Insomnia, Primary.

Filter by:

NCT ID: NCT03155750 Completed - Insomnia, Primary Clinical Trials

Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia

Start date: June 5, 2017
Phase: N/A
Study type: Interventional

Objectives: To evaluate the clinical effects of Zero-Time Exercise (ZTEx) for treating insomnia disorder delivered by a training course. Hypothesis: Subjects in the ZTEx training group will have greater improvement in insomnia symptoms and daytime impairment than those in the sleep hygiene education (SHE) group at week 8. Design and subjects: A randomized controlled trial. 32 inactive subjects with insomnia disorder recruited from the community will be randomized to ZTEx training or SHE groups in a 1: 1 ratio. Study instrument: Insomnia Severity Index (ISI) will be used to assess insomnia symptoms and daytime impairment. Interventions: Subjects in the ZTEx training group will attend two training lessons (2-hour each) to learn ZTEx and practice it every night for 8 weeks; subjects in the SHE group will receive sleep hygiene education with the schedule and duration that are same to the ZTEx training group. Main outcome measures: The primary outcome measure is the ISI score. Other measures include sleep parameters by subjective sleep diary and objective actigraphy, Hospital Anxiety and Depression Scale, Multidimensional Fatigue Inventory-20 and Short Form-6 Dimension. Acceptability and compliance of ZTEx will be evaluated. Data Analysis: Differences in the questionnaire scores, subjective and objective sleep parameters will be examined using a mixed-effects model.

NCT ID: NCT03109210 Active, not recruiting - Clinical trials for Sleep Apnea, Obstructive

Therapist-Directed VS Online Therapy for Insomnia Co-Occuring With Sleep Apnea

Start date: April 15, 2017
Phase: N/A
Study type: Interventional

This two-site randomized clinical trial will investigate and compare three treatments for insomnia in patients who have been diagnosed with and treated for sleep apnea: online cognitive behavioral therapy (OCBT), therapist-directed cognitive behavioral therapy (TCBT), and standard clinical care. 384 patients will be recruited and will attend up to 15 visits over 10 months. Visits will include baseline assessment, treatment visits, and post-treatment follow-up visits. Visits will involve completion of questionnaires, meeting with therapists, and a physical exam.

NCT ID: NCT03050372 Terminated - Insomnia, Primary Clinical Trials

Study of Low Field Magnetic Stimulation (LFMS) on Measures of Sleep

Start date: November 2016
Phase: N/A
Study type: Interventional

Participants will be recruited and screened through ongoing studies in the sleep and anxiety disorders clinic. Participants with insomnia will be consented to complete several questionnaires, undergo a brief physical exam, provide a urinalysis, and undergo 5 nights of active or sham Low Field Magnetic Stimulation (LFMS) followed by an overnight sleep study. Each of the two treatment conditions (active versus sham) will be conducted on two consecutive nights. There will be no more than 7 days between the adaptation night and the first treatment condition and no more than 7 nights between each of the two-night treatment conditions . Thus, each participant who completes the full study will spend a total of 5 nights in the sleep laboratory and the time interval from the first adaptation night to completion of the study may range from 5-19 days for any particular individual.

NCT ID: NCT03014960 Not yet recruiting - Chronic Insomnia Clinical Trials

Effects of Leader Sleep Improvement on Leadership

Start date: January 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the effects of sleep improvement in leaders on leader outcomes.

NCT ID: NCT02988375 Completed - Depression Clinical Trials

Sleep to Prevent Evolving Affecting Disorders

SPREAD
Start date: March 8, 2016
Phase: N/A
Study type: Interventional

The primary objective of the proposed research is to determine the efficacy of Digital Cognitive Behavior Therapy (dCBTI) in reducing severity of depression and also in preventing the incidence and relapse of depression among insomniacs. In addition, we will identify salient sociological/environmental variables, such as age, sex, education, socioeconomic status (SES), racial/ethnic minority-status, work schedule, child-care responsibilities (i.e., having children under the age of 3), stigma, that moderate the effects of this intervention.